This review focuses on the role of the chimeric BCR/ABL gene in leukem
ia development. First, we discuss and update knowledge regarding the m
olecular biology of BCR/ABL. We then review data regarding transformin
g activity of BCR/ABL. Third, we discuss the complex interactions betw
een BCR/ABL and leukemia phenotype. We conclude with a brief discussio
n of possible therapeutic implications of these data. Copyright (C) 19
96 Elsevier Science Ltd.